- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.24 Å
- Oligo State
- hetero-7-7-mer
- Ligands
- 14 x BEZ- LEU- LEU: 4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide(Non-covalent)
- 7 x AI4: 4-[1-[3-[4-[(4-fluoranyl-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-quinazolin-7-yl]oxypropyl]piperidin-4-yl]benzamide(Non-covalent)(Covalent)
AI4.15: 21 residues within 4Å:- Chain B: G.79, M.80, H.102, A.103, R.104, W.159
- Chain H: V.129, Q.131
- Chain I: S.55, I.56, S.57, M.60, G.112, G.113, Q.127, I.131, E.134, M.135, L.138
- Ligands: BEZ-LEU-LEU.1, BEZ-LEU-LEU.1
8 PLIP interactions:5 interactions with chain B, 3 interactions with chain I- Hydrophobic interactions: B:R.104, I:I.56, I:I.131, I:E.134
- Hydrogen bonds: B:H.102, B:R.104
- pi-Stacking: B:W.159
- pi-Cation interactions: B:R.104
AI4.16: 22 residues within 4Å:- Chain D: G.79, M.80, H.102, A.103, R.104, W.159
- Chain E: V.129, Q.131
- Chain K: S.55, I.56, S.57, M.60, G.112, G.113, T.115, Q.127, I.131, E.134, M.135, L.138
- Ligands: BEZ-LEU-LEU.5, BEZ-LEU-LEU.5
10 PLIP interactions:5 interactions with chain D, 3 interactions with chain K, 2 interactions with chain E- Hydrophobic interactions: D:R.104, K:I.56, K:E.134, E:Q.131
- Hydrogen bonds: D:H.102, D:R.104, K:S.57, E:Q.131
- pi-Stacking: D:W.159
- pi-Cation interactions: D:R.104
AI4.17: 22 residues within 4Å:- Chain C: V.129, Q.131
- Chain D: S.55, I.56, S.57, M.60, L.111, G.112, G.113, Q.127, I.131, E.134, M.135, L.138
- Chain G: G.79, M.80, H.102, A.103, R.104, W.159
- Ligands: BEZ-LEU-LEU.7, BEZ-LEU-LEU.7
11 PLIP interactions:8 interactions with chain G, 2 interactions with chain D, 1 interactions with chain C- Hydrophobic interactions: G:H.102, G:R.104, G:R.104, D:I.56, D:E.134, C:Q.131
- Hydrogen bonds: G:H.102, G:R.104
- pi-Stacking: G:W.159
- pi-Cation interactions: G:R.104, G:R.104
AI4.18: 21 residues within 4Å:- Chain I: G.79, M.80, H.102, A.103, R.104, W.159
- Chain J: V.129, Q.131
- Chain L: S.55, I.56, S.57, M.60, G.113, T.115, Q.127, I.131, E.134, M.135, L.138
- Ligands: BEZ-LEU-LEU.13, BEZ-LEU-LEU.13
7 PLIP interactions:4 interactions with chain I, 3 interactions with chain L- Hydrophobic interactions: I:R.104, L:I.56, L:I.131, L:E.134
- Hydrogen bonds: I:H.102
- pi-Stacking: I:W.159
- pi-Cation interactions: I:R.104
AI4.19: 20 residues within 4Å:- Chain A: V.129, Q.131
- Chain B: S.55, I.56, S.57, M.60, G.113, Q.127, I.131, E.134, M.135, L.138
- Chain K: G.79, M.80, H.102, A.103, R.104, W.159
- Ligands: BEZ-LEU-LEU.3, BEZ-LEU-LEU.3
10 PLIP interactions:6 interactions with chain K, 2 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: K:R.104, K:R.104, B:I.131, B:E.134, A:Q.131
- Hydrogen bonds: K:H.102, K:R.104, A:Q.131
- pi-Stacking: K:W.159
- pi-Cation interactions: K:R.104
AI4.20: 21 residues within 4Å:- Chain L: G.79, M.80, H.102, A.103, R.104, W.159
- Chain M: V.129, Q.131
- Chain N: S.55, I.56, S.57, M.60, G.113, T.115, Q.127, I.131, E.134, M.135, L.138
- Ligands: BEZ-LEU-LEU.11, BEZ-LEU-LEU.11
8 PLIP interactions:2 interactions with chain N, 6 interactions with chain L- Hydrophobic interactions: N:I.56, N:E.134, L:R.104
- Hydrogen bonds: L:H.102, L:R.104
- pi-Stacking: L:W.159
- pi-Cation interactions: L:R.104, L:R.104
AI4.21: 20 residues within 4Å:- Chain F: V.129, Q.131
- Chain G: S.55, I.56, S.57, M.60, G.113, Q.127, I.131, E.134, M.135, L.138
- Chain N: G.79, M.80, H.102, A.103, R.104, W.159
- Ligands: BEZ-LEU-LEU.9, BEZ-LEU-LEU.9
9 PLIP interactions:2 interactions with chain G, 1 interactions with chain F, 6 interactions with chain N- Hydrophobic interactions: G:I.56, G:E.134, N:R.104, N:R.104
- Hydrogen bonds: F:Q.131, N:H.102, N:R.104
- pi-Stacking: N:W.159
- pi-Cation interactions: N:R.104
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yang, Y. et al., Discovery and Mechanistic Study of Novel Mycobacterium tuberculosis ClpP1P2 Inhibitors. J.Med.Chem. (2023)
- Release Date
- 2023-04-12
- Peptides
- ATP-dependent Clp protease proteolytic subunit 2: ACEFHJM
ATP-dependent Clp protease proteolytic subunit 1: BDGIKLN - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CE
FF
HH
JJ
LM
EB
BD
DG
II
KK
ML
NN
G
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.24 Å
- Oligo State
- hetero-7-7-mer
- Ligands
- 14 x BEZ- LEU- LEU: 4-[[3,5-bis(fluoranyl)phenyl]methyl]-N-[(4-bromophenyl)methyl]piperazine-1-carboxamide(Non-covalent)
- 7 x AI4: 4-[1-[3-[4-[(4-fluoranyl-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-quinazolin-7-yl]oxypropyl]piperidin-4-yl]benzamide(Non-covalent)(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yang, Y. et al., Discovery and Mechanistic Study of Novel Mycobacterium tuberculosis ClpP1P2 Inhibitors. J.Med.Chem. (2023)
- Release Date
- 2023-04-12
- Peptides
- ATP-dependent Clp protease proteolytic subunit 2: ACEFHJM
ATP-dependent Clp protease proteolytic subunit 1: BDGIKLN - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CE
FF
HH
JJ
LM
EB
BD
DG
II
KK
ML
NN
G